Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Profit After Tax (2018 - 2025)

Historic Profit After Tax for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to -$4.4 million.

  • Regenerative Medical Technology's Profit After Tax fell 39075.81% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 million, marking a year-over-year decrease of 3622.84%. This contributed to the annual value of -$5.6 million for FY2024, which is 4331.4% up from last year.
  • As of Q3 2025, Regenerative Medical Technology's Profit After Tax stood at -$4.4 million, which was down 39075.81% from -$1.3 million recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Profit After Tax peaked at -$256037.0 during Q4 2023, and registered a low of -$9.9 million during Q3 2021.
  • For the 5-year period, Regenerative Medical Technology's Profit After Tax averaged around -$2.1 million, with its median value being -$1.5 million (2022).
  • Per our database at Business Quant, Regenerative Medical Technology's Profit After Tax surged by 8644.15% in 2022 and then plummeted by 39075.81% in 2025.
  • Over the past 5 years, Regenerative Medical Technology's Profit After Tax (Quarter) stood at -$1.6 million in 2021, then skyrocketed by 32.47% to -$1.1 million in 2022, then soared by 75.86% to -$256037.0 in 2023, then plummeted by 149.26% to -$638186.0 in 2024, then plummeted by 582.21% to -$4.4 million in 2025.
  • Its last three reported values are -$4.4 million in Q3 2025, -$1.3 million for Q2 2025, and -$760040.0 during Q1 2025.